Michael Harrop
Active member
https://www.reuters.com/legal/litigation/finch-wins-us-jury-trial-against-ferring-over-fecal-transplant-patents-2024-08-09/
Interesting.
Rebyota, a rectally delivered product developed by Ferring Pharmaceuticals, that secured FDA approval in November 2022.
Finch says Ferring infringed their patents, and the judge agreed with Finch, awarding them $25 million in damages and future royalties.
Interesting.
Rebyota, a rectally delivered product developed by Ferring Pharmaceuticals, that secured FDA approval in November 2022.
Finch says Ferring infringed their patents, and the judge agreed with Finch, awarding them $25 million in damages and future royalties.
- Format correct?
- Yes